In the present study, we evaluated the ATRX expression in NPC patients via immunohistochemistry and analyzed the correlation between ATRX expression and clinicopathological characteristics and patient's prognosis, and demonstrated that ATRX deficiency is correlated with earlier T stage and longer overall survival in NPC patients. This evidence concerns the gene ATRX and nasopharyngeal carcinoma.